Charles River Laboratories (CRL) Tops Q3 EPS by 9c; Boosts FY13 Outlook
Tweet Send to a Friend
Charles River Laboratories (NYSE: CRL) reported Q3 EPS of $0.79, $0.09 better than the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
